Aurenar

Overview

Aurenar, Inc is a neurotechnology startup based in Saint Louis, Missouri. The company develops a non-invasive, single-use neuromodulation platform aimed at reducing life-threatening complications caused by inflammation in intensive care units (ICUs). Aurenar's initial focus is on stroke, but the platform is designed for various other medical indications as well. The technology aims to improve patient outcomes and minimize complications, ultimately addressing the financial burden on healthcare systems associated with treating fragile patients.

Details

Category
Medical Equipment Manufacturing
Headquarters
Saint Louis, Missouri
Type
Privately Held
Followers
378
Locations
Saint Louis, Missouri, US

Similar companies